InsidersTradesSigma
Track the 중앙백신 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 중앙백신 has recorded 3 reports. Market capitalisation: €87.7bn. The latest transaction was reported on 15 June 2026 (Other). Among the most active insiders: 윤인중. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Central Vaccine is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and production of vaccines.